Please enable JavaScript to continue using this application.

Compare $ADPT vs $FTRE | Chartloom

Compare

$ADPT vs $FTRE

Adaptive Biotechnologies Corp · Fortrea Holdings Inc

ADPT

Adaptive Biotechnologies Corp

FTRE

Fortrea Holdings Inc

Compare $ADPT vs $FTRE

Comparing Adaptive Biotechnologies Corp and Fortrea Holdings Inc

ADPTAdaptive Biotechnologies Corp

FTREFortrea Holdings Inc

ADPTAdaptive Biotechnologies Corp

Market cap

$4.21B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.97x

Rev growth (TTM)

50.1%

YTD performance

66.5%

52W performance

70.4%

FCF yield

-0.6%

FTREFortrea Holdings Inc

Market cap

$1.98B

P/E (TTM)

—

Forward P/E (NTM)

21.43x

Forward P/S (NTM)

0.72x

Rev growth (TTM)

-2.1%

YTD performance

24.0%

52W performance

105.7%

FCF yield

9.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ADPT

FTRE

Detailed metrics comparison

ADPT

Adaptive Biotechnologies Corp

FTRE

Fortrea Holdings Inc

Market Cap

ADPT$4.21B

FTRE$1.98B

Enterprise Value

ADPT$4.38B

FTRE$2.87B

Price

ADPT$26.49

FTRE$20.84

P/E Ratio

ADPTN/A

FTREN/A

P/S Ratio

ADPT13.68x

FTRE0.74x

EV/Sales

ADPT14.21x

FTRE1.07x

EV/EBITDA

ADPT0.00x

FTRE27.52x

P/B Ratio

ADPT31.66x

FTRE3.63x

P/FCF Ratio

ADPTN/A

FTRE10.11x

EV/FCF

ADPT-182.18x

FTRE14.63x

PEG Ratio

ADPTN/A

FTREN/A

Forward P/E (NTM)

ADPTN/A

FTRE21.43x

Forward P/S (NTM)

ADPT12.97x

FTRE0.72x

Revenue (TTM)

ADPT$308M

FTRE$2.68B

Revenue Growth (YoY)

ADPT50.1%

FTRE-2.1%

Forward Rev Growth

ADPT22.3%

FTRE3.1%

Gross Margin (TTM)

ADPT75.6%

FTRE19.3%

Operating Margin (TTM)

ADPT0.0%

FTRE0.0%

EBITDA Margin (TTM)

ADPT-6.7%

FTRE3.9%

Net Margin (TTM)

ADPT-20.7%

FTRE-3.2%

FCF Margin (TTM)

ADPT-7.8%

FTRE7.3%

Net Income (TTM)

ADPT$-64M

FTRE$-85M

FCF (TTM)

ADPT$-24M

FTRE$196M

EPS (TTM)

ADPT-$0.40

FTRE-$0.90

ROE (TTM)

ADPT-3264.0%

FTRE-1553.0%

ROA (TTM)

ADPT-1188.0%

FTRE-314.0%

ROIC (TTM)

ADPT-1690.0%

FTRE-526.0%

Cash

ADPT$170M

FTRE$169M

Debt

ADPT$335M

FTRE$1.05B

Net Cash/Debt

ADPT$-165M

FTRE$-886M

Current Ratio (TTM)

ADPT4.79x

FTRE0.96x

Quick Ratio (TTM)

ADPT4.51x

FTRE0.85x

Debt/Equity (TTM)

ADPT2.34x

FTRE2.01x

Debt/Assets (TTM)

ADPT0.0%

FTRE0.0%

Interest Coverage (TTM)

ADPTN/A

FTREN/A

Net Debt/EBITDA (TTM)

ADPT0.00x

FTRE0.00x

Beta

ADPT2.16

FTRE1.93

52W Performance

ADPT70.4%

FTRE105.7%

YTD Performance

ADPT66.5%

FTRE24.0%

% from 52W High

ADPT-13.8%

FTRE-11.4%

% from 52W Low

ADPT120.7%

FTRE143.7%

Asset Turnover (TTM)

ADPT0.57x

FTRE0.99x

FCF Yield (TTM)

ADPT-0.6%

FTRE9.9%

Earnings Yield (TTM)

ADPT-1.5%

FTRE-4.3%

Dividend Yield (TTM)

ADPTN/A

FTREN/A

Rule of 40

ADPT42.3

FTRE5.2

EV/GP/RG

ADPT3.28

FTRE1.88

Ticker research

View ADPT research View FTRE research

Metric	ADPT Adaptive Biotechnologies Corp	FTRE Fortrea Holdings Inc
Market & Valuation
Market Cap	$4.21B	$1.98B
Enterprise Value	$4.38B	$2.87B
Price	$26.49	$20.84
P/E Ratio	N/A	N/A
P/S Ratio	13.68x	0.74x
EV/Sales	14.21x	1.07x
EV/EBITDA	0.00x	27.52x
P/B Ratio	31.66x	3.63x
P/FCF Ratio	N/A	10.11x
EV/FCF	-182.18x	14.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	21.43x
Forward P/S (NTM)	12.97x	0.72x
Revenue & Growth
Revenue (TTM)	$308M	$2.68B
Revenue Growth (YoY)	50.1%	-2.1%
Forward Rev Growth	22.3%	3.1%
Profitability
Gross Margin (TTM)	75.6%	19.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6.7%	3.9%
Net Margin (TTM)	-20.7%	-3.2%
FCF Margin (TTM)	-7.8%	7.3%
Net Income (TTM)	$-64M	$-85M
FCF (TTM)	$-24M	$196M
EPS (TTM)	-$0.40	-$0.90
ROE (TTM)	-3264.0%	-1553.0%
ROA (TTM)	-1188.0%	-314.0%
ROIC (TTM)	-1690.0%	-526.0%
Financial Health
Cash	$170M	$169M
Debt	$335M	$1.05B
Net Cash/Debt	$-165M	$-886M
Current Ratio (TTM)	4.79x	0.96x
Quick Ratio (TTM)	4.51x	0.85x
Debt/Equity (TTM)	2.34x	2.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.16	1.93
52W Performance	70.4%	105.7%
YTD Performance	66.5%	24.0%
% from 52W High	-13.8%	-11.4%
% from 52W Low	120.7%	143.7%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.99x
FCF Yield (TTM)	-0.6%	9.9%
Earnings Yield (TTM)	-1.5%	-4.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.3	5.2
EV/GP/RG	3.28	1.88
Ticker research	View ADPT research	View FTRE research

Valuation

P/S Ratio

FTRE

0.74x

ADPT

13.68x

EV/FCF

ADPT

-182.18x

FTRE

14.63x

Growth & revenue

Revenue Growth TTM

ADPT

50.1%

FTRE

-2.1%

Forward Revenue Growth

ADPT

22.3%

FTRE

3.1%

Profitability & performance

Gross Margin

ADPT

75.6%

FTRE

19.3%

ROE

FTRE

-1553.0%

ADPT

-3264.0%

FCF Yield %

FTRE

9.9%

ADPT

-0.6%

52-Week Performance

FTRE

105.7%

ADPT

70.4%

Detailed metrics comparison

ADPT

Adaptive Biotechnologies Corp

FTRE

Fortrea Holdings Inc

Market Cap

ADPT$4.21B

FTRE$1.98B

Enterprise Value

ADPT$4.38B

FTRE$2.87B

Price

ADPT$26.49

FTRE$20.84

P/E Ratio

ADPTN/A

FTREN/A

P/S Ratio

ADPT13.68x

FTRE0.74x

EV/Sales

ADPT14.21x

FTRE1.07x

EV/EBITDA

ADPT0.00x

FTRE27.52x

P/B Ratio

ADPT31.66x

FTRE3.63x

P/FCF Ratio

ADPTN/A

FTRE10.11x

EV/FCF

ADPT-182.18x

FTRE14.63x

PEG Ratio

ADPTN/A

FTREN/A

Forward P/E (NTM)

ADPTN/A

FTRE21.43x

Forward P/S (NTM)

ADPT12.97x

FTRE0.72x

Revenue (TTM)

ADPT$308M

FTRE$2.68B

Revenue Growth (YoY)

ADPT50.1%

FTRE-2.1%

Forward Rev Growth

ADPT22.3%

FTRE3.1%

Gross Margin (TTM)

ADPT75.6%

FTRE19.3%

Operating Margin (TTM)

ADPT0.0%

FTRE0.0%

EBITDA Margin (TTM)

ADPT-6.7%

FTRE3.9%

Net Margin (TTM)

ADPT-20.7%

FTRE-3.2%

FCF Margin (TTM)

ADPT-7.8%

FTRE7.3%

Net Income (TTM)

ADPT$-64M

FTRE$-85M

FCF (TTM)

ADPT$-24M

FTRE$196M

EPS (TTM)

ADPT-$0.40

FTRE-$0.90

ROE (TTM)

ADPT-3264.0%

FTRE-1553.0%

ROA (TTM)

ADPT-1188.0%

FTRE-314.0%

ROIC (TTM)

ADPT-1690.0%

FTRE-526.0%

Cash

ADPT$170M

FTRE$169M

Debt

ADPT$335M

FTRE$1.05B

Net Cash/Debt

ADPT$-165M

FTRE$-886M

Current Ratio (TTM)

ADPT4.79x

FTRE0.96x

Quick Ratio (TTM)

ADPT4.51x

FTRE0.85x

Debt/Equity (TTM)

ADPT2.34x

FTRE2.01x

Debt/Assets (TTM)

ADPT0.0%

FTRE0.0%

Interest Coverage (TTM)

ADPTN/A

FTREN/A

Net Debt/EBITDA (TTM)

ADPT0.00x

FTRE0.00x

Beta

ADPT2.16

FTRE1.93

52W Performance

ADPT70.4%

FTRE105.7%

YTD Performance

ADPT66.5%

FTRE24.0%

% from 52W High

ADPT-13.8%

FTRE-11.4%

% from 52W Low

ADPT120.7%

FTRE143.7%

Asset Turnover (TTM)

ADPT0.57x

FTRE0.99x

FCF Yield (TTM)

ADPT-0.6%

FTRE9.9%

Earnings Yield (TTM)

ADPT-1.5%

FTRE-4.3%

Dividend Yield (TTM)

ADPTN/A

FTREN/A

Rule of 40

ADPT42.3

FTRE5.2

EV/GP/RG

ADPT3.28

FTRE1.88

Ticker research

View ADPT research View FTRE research

Metric	ADPT Adaptive Biotechnologies Corp	FTRE Fortrea Holdings Inc
Market & Valuation
Market Cap	$4.21B	$1.98B
Enterprise Value	$4.38B	$2.87B
Price	$26.49	$20.84
P/E Ratio	N/A	N/A
P/S Ratio	13.68x	0.74x
EV/Sales	14.21x	1.07x
EV/EBITDA	0.00x	27.52x
P/B Ratio	31.66x	3.63x
P/FCF Ratio	N/A	10.11x
EV/FCF	-182.18x	14.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	21.43x
Forward P/S (NTM)	12.97x	0.72x
Revenue & Growth
Revenue (TTM)	$308M	$2.68B
Revenue Growth (YoY)	50.1%	-2.1%
Forward Rev Growth	22.3%	3.1%
Profitability
Gross Margin (TTM)	75.6%	19.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6.7%	3.9%
Net Margin (TTM)	-20.7%	-3.2%
FCF Margin (TTM)	-7.8%	7.3%
Net Income (TTM)	$-64M	$-85M
FCF (TTM)	$-24M	$196M
EPS (TTM)	-$0.40	-$0.90
ROE (TTM)	-3264.0%	-1553.0%
ROA (TTM)	-1188.0%	-314.0%
ROIC (TTM)	-1690.0%	-526.0%
Financial Health
Cash	$170M	$169M
Debt	$335M	$1.05B
Net Cash/Debt	$-165M	$-886M
Current Ratio (TTM)	4.79x	0.96x
Quick Ratio (TTM)	4.51x	0.85x
Debt/Equity (TTM)	2.34x	2.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.16	1.93
52W Performance	70.4%	105.7%
YTD Performance	66.5%	24.0%
% from 52W High	-13.8%	-11.4%
% from 52W Low	120.7%	143.7%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.99x
FCF Yield (TTM)	-0.6%	9.9%
Earnings Yield (TTM)	-1.5%	-4.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.3	5.2
EV/GP/RG	3.28	1.88
Ticker research	View ADPT research	View FTRE research